Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-07-25

FDA Approved: ABACAVIR AND LAMIVUDINE — Original Application (Laurus Labs Limited)

View source ↗

Summary

FDA approved Laurus Labs Limited's generic fixed-dose combination tablet of abacavir and lamivudine (ABACAVIR AND LAMIVUDINE) under an Original Application (AND…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ABACAVIR AND LAMIVUDINE (abacavir/lamivudine)

Snippet

ORIG AP for ABACAVIR AND LAMIVUDINE (ABACAVIR AND LAMIVUDINE)